Contracts License Agreements

  • Dec 19- Swiss drugmaker Novartis on Monday said it signed a licensing deal to co-develop a fatty liver disease drug with Conatus Pharmaceuticals Inc, under which the small U.S. company will receive $50 million up front. Conatus shares rose to $4.20 in extended trading from a Nasdaq close at $1.96. Conatus has the option to co-commercialize emricasan in the...

  • Dec 19- Swiss drugmaker Novartis on Monday said it signed a licensing deal to co-develop a fatty liver disease drug with Conatus Pharmaceuticals Inc, under which the small U.S. company will receive $50 million up front. Conatus has the option to co-commercialize emricasan in the United States. It is estimated that NASH affects 3 percent to 5 percent of the U.S....

  • -Feb 2016: Investment of $42.5 million in Pronutria Biosciences, now Axcella Health, a specialist in developing medicines for disease caused by amino acid imbalance. -Sept 2015: Licensing agreement with Lipid Therapeutics for exclusive worldwide rights, except for Europe and Australia, to its experimental medicine for ulcerative colitis.

  • -Feb 2016: Investment of $42.5 million in Pronutria Biosciences, now Axcella Health, a specialist in developing medicines for disease caused by amino acid imbalance. -Sept 2015: Licensing agreement with Lipid Therapeutics for exclusive worldwide rights, except for Europe and Australia, to its experimental medicine for ulcerative colitis.

  • -Feb 2016: Investment of $42.5 million in Pronutria Biosciences, now Axcella Health, a specialist in developing medicines for disease caused by amino acid imbalance. -Sept 2015: Licensing agreement with Lipid Therapeutics for exclusive worldwide rights, except for Europe and Australia, to its experimental medicine for ulcerative colitis.

  • WASHINGTON, Aug 4- As the U.S. Treasury Department decides whether to license sales of Boeing Co and Airbus commercial aircraft to Iran, opponents of last year's nuclear pact with the Islamic republic have launched a lobbying campaign against the deals. The international agreement to curb Iran's nuclear program made such sales possible by easing sanctions on...

  • Pandora CFO: A new paradigm for music consumption

    Michael Herring, CFO at Pandora, discusses the music streaming company's outlook as well as how Pandora stacks up against competitors.